One mid-cap stock that could have significant upside is healthcare company NovoCure (NASDAQ: NVCR), which makes tumor treating fields (TTF) devices. There are some exciting ongoing studies in the company's pipeline that could make it a hot growth stock for years to come. A big reason NovoCure could have millionaire-making potential is its focus on some hard-to-treat, aggressive forms of cancer.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles